Literature DB >> 28965451

Instrumented fusion for spinal deformity after laminectomy or laminoplasty for resection of intramedullary spinal cord tumors in pediatric patients.

David S Hersh1, Rajiv R Iyer2, Tomas Garzon-Muvdi2, Ann Liu2, George I Jallo2,3, Mari L Groves1,2.   

Abstract

OBJECTIVE Spinal deformity has become a well-recognized complication of intramedullary spinal cord tumor (IMSCT) resection. In particular, laminectomy can result in biomechanical instability caused by loss of the posterior tension band. Therefore, laminoplasty has been proposed as an alternative to laminectomy. Here, the authors describe the largest current series of pediatric patients who have undergone laminoplasty for IMSCT resection and investigate the need for surgical fusion after both laminectomy and laminoplasty. METHODS The medical records of pediatric patients who underwent resection of an IMSCT at a single institution between November 2003 and May 2014 were reviewed retrospectively. Demographic, clinical, radiological, surgical, histopathological, and follow-up data were collected. RESULTS Sixty-six consecutive patients underwent resection of an IMSCT during the study period. Forty-three (65%) patients were male. The patients had a median age of 12.9 years (interquartile range [IQR] 7.2-16.5 years) at the time of surgery. Patients typically presented with a tumor that involved the cervical and/or thoracic spine. Nineteen (29%) patients underwent laminectomy, and 47 (71%) patients underwent laminoplasty. Patients in each cohort had a similar rate of postoperative deformity. Overall, 10 (15%) patients required instrumented spinal fusion for spinal deformity. Four patients required revision of the primary fusion. CONCLUSIONS These findings show that among pediatric patients with an IMSCT, postoperative surgical fusion rates remain high, even after laminoplasty. Known risk factors, such as the age of the patient, location of the tumor, and the number of involved levels, might play a larger role than replacement of the laminae in determining the rate of surgical fusion after IMSCT resection.

Entities:  

Keywords:  IMSCT = intramedullary spinal cord tumor; IQR = interquartile range; MEP = motor evoked potential; deformity; fusion; intramedullary; kyphosis; laminoplasty; scoliosis

Mesh:

Year:  2017        PMID: 28965451     DOI: 10.3171/2017.7.FOCUS17329

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  6 in total

1.  Incidence and Predictors of Postoperative Kyphotic Deformity after Thoracic Spinal Cord Tumor Resection.

Authors:  Hideyuki Arima; Tomohiko Hasegawa; Yu Yamato; Go Yoshida; Tomohiro Banno; Shin Oe; Yuki Mihara; Hiroki Ushirozako; Tomohiro Yamada; Koichiro Ide; Yuh Watanabe; Keiichi Nakai; Kenta Kurosu; Yukihiro Matsuyama
Journal:  Spine Surg Relat Res       Date:  2021-08-23

2.  Intramedullary Spinal Cord Lesions: A Single-Center Experience.

Authors:  Vincent Jecko; Paul Roblot; Lorenzo Mongardi; Morgan Ollivier; Natalia Delgado Piccoli; Thomas Charleux; Thomas Wavasseur; Edouard Gimbert; Dominique Liguoro; Guillaume Chotard; Jean-Rodolphe Vignes
Journal:  Neurospine       Date:  2022-03-31

Review 3.  Surgical approaches to intramedullary spinal cord astrocytomas in the age of genomics.

Authors:  Andrew M Hersh; George I Jallo; Nir Shimony
Journal:  Front Oncol       Date:  2022-09-06       Impact factor: 5.738

Review 4.  Instrumentation following intradural tumor resection: A case analyses and literature review.

Authors:  Brandon Michael Wilkinson; Michael Galgano
Journal:  Surg Neurol Int       Date:  2020-05-30

5.  Laminectomy Versus Laminoplasty in the Surgical Management of Long-Segment Intradural Spinal Tumors: Any Difference in Neurological Outcomes?

Authors:  Chiazor U Onyia; Sajesh K Menon
Journal:  Asian J Neurosurg       Date:  2018 Oct-Dec

6.  Risk factor analysis for progressive spinal deformity after resection of intracanal tumors─ a retrospective study of 272 cases.

Authors:  Pangbo Wang; Kang Ma; Tunan Chen; Xingsen Xue; Dada Ma; Shi Wang; Xin Chen; Hui Meng; Gaoyu Cui; Boyuan Gao; Jiangkai Lin; Hua Feng; Weihua Chu
Journal:  BMC Neurol       Date:  2020-01-23       Impact factor: 2.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.